Yogesh N.V. Reddy

Oct 30, 2024 | onlinelibrary.wiley.com | Yogesh N.V. Reddy |Javed Butler |Baylor Scott |Kevin J. Anstrom

Introduction Vericiguat, a soluble guanylate cyclase stimulator, is approved in many countries for the treatment of worsening heart failure (HF) with reduced ejection fraction (HFrEF).

Aug 19, 2024 | onlinelibrary.wiley.com | Jacob C. Jentzer |Yogesh N.V. Reddy |Sabri Soussi |Ruben Crespo-Diaz

Introduction The heterogeneity of the modern cardiac intensive care unit (CICU) has expanded, reflecting a transition from patients with acute coronary syndrome (ACS) to patients with circulatory failure.1, 2 Heart failure (HF) is becoming the most common diagnosis in contemporary CICU populations.1-3 Patients with HF in the CICU encompass a wide spectrum of acuity and chronic illness severity and are at elevated risk of adverse outcomes (particularly the important minority with advanced...

Jul 17, 2024 | onlinelibrary.wiley.com | Yogesh N.V. Reddy |Varun Sundaram

• , , , , , , et al.; . Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction . N Engl J Med ; : – . https://doi.org/10.1056/NEJMoa2206286• , , , , , , et al.; . Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: A pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials . Lancet ; : – . https://doi.org/10.1016/S0140-6736(24)00469-0• , , , , , , et al.; .

Jun 26, 2024 | onlinelibrary.wiley.com | Yogesh N.V. Reddy |Varun Sundaram

Invited Editorial Towards more practical phenotyping in heart failure with preserved ejection fraction Yogesh N.V. Reddy,  Corresponding Author Yogesh N.V. Reddy Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA Corresponding author. Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

Jun 1, 2024 | jacc.org | Yogesh N.V. Reddy |Peter A. Noseworthy |Barry A. Borlaug |Nancy M. Albert

References1. "Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation". J Am Coll Cardiol . 2020;76:1051-1064. 2. "Management of atrial fibrillation across the spectrum of heart failure with preserved and reduced ejection fraction". Circulation . 2022;146:339-357. 3. "Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction". Circulation . 2016;133:484-492. 4.